[go: up one dir, main page]

WO2009057133A3 - Procédé de synthèse d'acide 2-[2-[4-[(4-chlorophényl)phénylméthyl]-1-pipérazinyl]éthoxy-acétique - Google Patents

Procédé de synthèse d'acide 2-[2-[4-[(4-chlorophényl)phénylméthyl]-1-pipérazinyl]éthoxy-acétique Download PDF

Info

Publication number
WO2009057133A3
WO2009057133A3 PCT/IN2008/000419 IN2008000419W WO2009057133A3 WO 2009057133 A3 WO2009057133 A3 WO 2009057133A3 IN 2008000419 W IN2008000419 W IN 2008000419W WO 2009057133 A3 WO2009057133 A3 WO 2009057133A3
Authority
WO
WIPO (PCT)
Prior art keywords
piperazinyl
acetic acid
phenyl methyl
chlorophenyl
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2008/000419
Other languages
English (en)
Other versions
WO2009057133A2 (fr
Inventor
Santosh Ramesh Badgujar
Hemant Harishchandra Kamble
Vipin Sharma
Dharmeshkumar Arvindbhai Patel
Mubeen Ahmed Khan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glenmark Generics Ltd
Original Assignee
Glenmark Generics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Generics Ltd filed Critical Glenmark Generics Ltd
Publication of WO2009057133A2 publication Critical patent/WO2009057133A2/fr
Anticipated expiration legal-status Critical
Publication of WO2009057133A3 publication Critical patent/WO2009057133A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention concerne un procédé de préparation d'acide 2-[2-[4-[(4-chlorophényl)phénylméthyl]-1-pipérazinyl]éthoxy-acétique de formule (Ia) et de ses sels pharmaceutiquement acceptables, et de composés de formule (IIa) et (VIIIa), dans lesquelles R1 représente H ou un groupe alkyle en C1-C4 ; R2 représente un groupe aryle ou hétéroaryle ou R1 et R2 associés à l'atome de carbone auxquels ils sont attachés forment un groupe cycloalkyle en C3-C8 et X représente un groupe labile approprié, par exemple un atome de chlore, de brome, d'iode, un groupe 4-méthylphényl-sulfonyloxy, méthylsulfonyloxy ou 4-bromophényl-sulfonyloxy.
PCT/IN2008/000419 2007-07-24 2008-07-03 Procédé de synthèse d'acide 2-[2-[4-[(4-chlorophényl)phénylméthyl]-1-pipérazinyl]éthoxy-acétique Ceased WO2009057133A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1428/MUM/2007 2007-07-24
IN1428MU2007 2007-07-24
IN1875MU2007 2007-09-24
IN1875/MUM/2007 2007-09-24

Publications (2)

Publication Number Publication Date
WO2009057133A2 WO2009057133A2 (fr) 2009-05-07
WO2009057133A3 true WO2009057133A3 (fr) 2011-01-06

Family

ID=40591602

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2008/000419 Ceased WO2009057133A2 (fr) 2007-07-24 2008-07-03 Procédé de synthèse d'acide 2-[2-[4-[(4-chlorophényl)phénylméthyl]-1-pipérazinyl]éthoxy-acétique

Country Status (1)

Country Link
WO (1) WO2009057133A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101928223A (zh) * 2009-06-26 2010-12-29 华东理工大学 一种(r)-(-)-4-氯二苯甲胺的拆分方法
CN103044355A (zh) * 2011-10-13 2013-04-17 湖南九典制药有限公司 合成左西替利嗪的关键中间体及其制备方法
JP7654243B2 (ja) * 2020-02-28 2025-04-01 国立大学法人東海国立大学機構 変異型ｇタンパク質共役型受容体
CN117209453A (zh) * 2023-08-24 2023-12-12 迪嘉药业集团股份有限公司 一种盐酸左西替利嗪中间体的制备及应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525358A (en) * 1981-02-06 1985-06-25 Ucb Pharmaceuticals, Inc. 2-[4-(Diphenylmethyl)-1-piperazinyl]-acetic acids and their amides
US6046332A (en) * 1996-07-11 2000-04-04 Tao; Yong Methods for the manufacture of cetirizine
CN101100462A (zh) * 2007-08-02 2008-01-09 河北师范大学 左旋西替利嗪盐酸盐的一种合成方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525358A (en) * 1981-02-06 1985-06-25 Ucb Pharmaceuticals, Inc. 2-[4-(Diphenylmethyl)-1-piperazinyl]-acetic acids and their amides
US6046332A (en) * 1996-07-11 2000-04-04 Tao; Yong Methods for the manufacture of cetirizine
CN101100462A (zh) * 2007-08-02 2008-01-09 河北师范大学 左旋西替利嗪盐酸盐的一种合成方法

Also Published As

Publication number Publication date
WO2009057133A2 (fr) 2009-05-07

Similar Documents

Publication Publication Date Title
JP2011037870A5 (fr)
NZ597381A (en) Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
JP2013508413A5 (fr)
WO2007060257A3 (fr) Dicetopyrrolo-pyrroles
MX2010004435A (es) Compuestos espiro y uso farmaceutico de los mismos.
WO2007105253A8 (fr) Procédé de préparation de dérivés de (1-oxa ou 1-thia)-3-céphem et d'intermédiaires apparentés
JP2006508935A5 (fr)
CA2796933A1 (fr) Derives d'acide 1-(2-fluorobiphenyl-4-yle)-alkyl-carboxylique pour la therapie de l'amyloidose de la transthyretine
ZA200708159B (en) 1-Acetic acid-indole derivatives with PDG2 antagonist activity
EP1798226A4 (fr) Derive de traizol
JP2010502730A5 (fr)
WO2009057133A3 (fr) Procédé de synthèse d'acide 2-[2-[4-[(4-chlorophényl)phénylméthyl]-1-pipérazinyl]éthoxy-acétique
WO2008087611A3 (fr) Dérivés de pyrrolidine et de piperidine
WO2010033643A3 (fr) Composés à petite molécule pour la différenciation de cellules souches
EA201270099A1 (ru) Транс-4-[[(5s)-5-[[[3,5-бис(трифторметил)фенил]метил](2-метил-2h-тетразол-5-ил)амино]-2,3,4,5-тетрагидро-7,9-диметил-1h-1-бензазепин-1-ил]метил]циклогексанкарбоновая кислота
DK2000465T3 (da) Triazolonderivat
BR112013021848A2 (pt) 5-(fenil/piridinil-etinil)-2-piridina/2-pirimidina-carboxamidas como moduladores de mglur5
WO2007133481A3 (fr) Méthode d'augmentation de la biodisponibilité de composés contenant de la benzhydrylpipérazine
WO2008136389A1 (fr) Composé amide et son utilisation pour éliminer les maladies des plantes
WO2008136388A1 (fr) Composé amide et son utilisation pour éliminer les maladies des plantes
WO2008003855A3 (fr) Utilisation de 2-benzoyl-imidazopyridines en thérapeutique
IL200323A0 (en) Synthesis of glyt-1 inhibitors
TN2011000474A1 (en) Pyrazole compound
JP2012522840A5 (fr)
WO2009106750A3 (fr) Dérivés 6-heterocyclique-imidazo[1,2-a]pyrroine-2-carboxamides, leur préparation et leur application en thérapeutique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08845197

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08845197

Country of ref document: EP

Kind code of ref document: A2